Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Hatt

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Medical Physics|May 12, 2017
Evaluation of the tumor registration error in biopsy procedures performed under real-time PET/CT guidanceLouise M Fanchon, Adytia Apte, C Ross Schmidtlein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 20, 2017
FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancerPierre Lovinfosse, Marc Polus, Daniel Van Daele, et al.
Radiology|April 28, 2015
Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer SubtypeDavid Groheux, Mohamed Majdoub, Alice Sanna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2015
Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast CancerDavid Groheux, Alice Sanna, Mohamed Majdoub, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 6, 2017
Independent component analysis for rectal bleeding prediction following prostate cancer radiotherapyAuréline Fargeas, Oscar Acosta, Juan David Ospina Arrango, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 12, 2018
External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapyFrançois Lucia, Dimitris Visvikis, Martin Vallières, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2016
Performance of automatic image segmentation algorithms for calculating total lesion glycolysis for early response monitoring in non-small cell lung cancer patients during concomitant chemoradiotherapyWillem Grootjans, Edwin A Usmanij, Wim J G Oyen, et al.
Oncotarget|March 9, 2018
Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using <sup>18</sup>F-fluoromisonidazole PET/CT: a pilot studyStéphane Supiot, Caroline Rousseau, Mélanie Dore, et al.
Cancer|March 19, 2013
Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapyDavid Groheux, Mathieu Hatt, Elif Hindié, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Reoxygenation during radiotherapy in intermediate-risk prostate cancerStéphane Supiot, Caroline Rousseau, Mélanie Dore, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Medical Physics|May 12, 2017
Evaluation of the tumor registration error in biopsy procedures performed under real-time PET/CT guidanceLouise M Fanchon, Adytia Apte, C Ross Schmidtlein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 20, 2017
FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancerPierre Lovinfosse, Marc Polus, Daniel Van Daele, et al.
Radiology|April 28, 2015
Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer SubtypeDavid Groheux, Mohamed Majdoub, Alice Sanna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2015
Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast CancerDavid Groheux, Alice Sanna, Mohamed Majdoub, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 6, 2017
Independent component analysis for rectal bleeding prediction following prostate cancer radiotherapyAuréline Fargeas, Oscar Acosta, Juan David Ospina Arrango, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 12, 2018
External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapyFrançois Lucia, Dimitris Visvikis, Martin Vallières, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2016
Performance of automatic image segmentation algorithms for calculating total lesion glycolysis for early response monitoring in non-small cell lung cancer patients during concomitant chemoradiotherapyWillem Grootjans, Edwin A Usmanij, Wim J G Oyen, et al.
Oncotarget|March 9, 2018
Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using <sup>18</sup>F-fluoromisonidazole PET/CT: a pilot studyStéphane Supiot, Caroline Rousseau, Mélanie Dore, et al.
Cancer|March 19, 2013
Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapyDavid Groheux, Mathieu Hatt, Elif Hindié, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Reoxygenation during radiotherapy in intermediate-risk prostate cancerStéphane Supiot, Caroline Rousseau, Mélanie Dore, et al.
Pageof 12